Abstract
This is the fifth article in a series of five on new radiopharmaceuticals. Upon completion, the technologist will be able to (1) list the characteristics of tetrofosmin, (2) describe the clinical images, and (3) compare tetrofosmin to other myocardial perfusion agents.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.